Skip to main content
. 2022 Nov 24;23(4):61–72. doi: 10.1038/s41397-022-00297-1

Table 3.

The intersection of top 50 drugs by activity (Method 1) and connectivity (Method 2) scores on PPARA pathway.

Drug name Dose (µM) Na Rank by Activity score (Method 1) Connectivity score (Method 2)
Activity score difference (ASd)b Connectivity score Treatment (ASt) Control (ASc) Difference (ASd)
Anisomycin 15 2 1 15 2.71 −0.26 2.96 −0.66
Cephaeline 6 3 2 48 3.01 0.61 2.4 −0.58
Pararosaniline 10 1 3 4 2.52 0.3 2.22 −0.73
Cycloheximide 14.2 2 6 39 2.05 −0.02 2.08 −0.61
Monensin 10.9 1 17 21 0.34 −1.23 1.57 −0.64
Wortmannin 1 2 18 44 2.75 1.18 1.56 −0.6
Raloxifene 0.1 1 24 47 0.72 −0.66 1.38 −0.58
Prednisolone 1 1 25 8 0.65 −0.73 1.38 −0.71
Valinomycin 0.1 2 34 29 1.11 −0.09 1.2 −0.62
Oligomycin 1 1 37 31 0.51 −0.63 1.15 −0.62
Mepacrine 7.8 1 44 14 0.93 −0.1 1.03 −0.66
5186324 2 1 47 20 1.31 0.3 1.01 −0.65
5162773 7 1 48 30 1.31 0.3 1.01 −0.62

aThe number of experiments.

bActivity difference = activity score in treatment (ASt) − activity score in control (ASc).